Previous Section Index Home Page

20 Apr 2009 : Column 473W—continued

Mid Staffordshire NHS Foundation Trust: Managers

Mr. Lansley: To ask the Secretary of State for Health whether his Department (a) was informed in advance of and (b) agreed to the suspension of the Chief Executive of Mid Staffordshire NHS Foundation Trust. [269718]

Mr. Bradshaw: The suspension of the chief executive is entirely a matter for the NHS foundation trust and its chairman.

Midwives: Training

Norman Lamb: To ask the Secretary of State for Health what proportion of midwives in service qualified by completing a midwifery (a) degree and (b) short programme before registration. [269213]

Ann Keen: This information is not collected centrally.


20 Apr 2009 : Column 474W

Multiple Sclerosis: Research

Mr. Burrowes: To ask the Secretary of State for Health what research he has (a) commissioned and (b) evaluated on a possible link between vitamin D and a common genetic variant which lowers the risk of developing multiple sclerosis; and if he will make a statement. [267953]

Dawn Primarolo: The Department has made no assessment of evidence on a possible link between vitamin D and a common genetic variant which lowers the risk of developing multiple sclerosis.

Current Government policy recommends a dietary supplementation of vitamin D in certain groups including all pregnant and breastfeeding women, children from six months up to the age of five years and people aged over 65 years or housebound.

Musculoskeletal Disorders: Waiting Lists

Mr. Lansley: To ask the Secretary of State for Health what assessment he has made of the (a) median and (b) mean length of time a patient has waited for (i) an outpatient and (ii) an inpatient appointment in the (A) orthopaedic and (B) rheumatology specialty since 1997, as measured by the (1) Korner and (2) Hospital Episodes Statistics databases, broken down by strategic health authority area. [249246]

Mr. Bradshaw: The median and mean time a patient waited for an out-patient and in-patient appointment for orthopaedics and rheumatology since 2002, when strategic health authorities were established, as measured by Korner and Hospital Episodes Statistics (HES) are available in the document ‘Trauma & Orthopaedics and Rheumatology—Median and Mean 2002 to January 2009’, which has been placed in the Library.

The median referral to treatment time waited of patients who were admitted for treatment has come down from 18.8 weeks in March 2007 to 8.6 weeks in January 2009. Median referral to treatment time waited for non-admitted patients was 4.6 weeks in January 2009, compared to 7.4 weeks in August 2007.

The median referral to treatment time waited of trauma and orthopaedic patients admitted for treatment has come down from 29.5 weeks in March 2007 to 12.6 weeks in January 2009. Median referral to treatment time waited for non-admitted trauma and orthopaedic patients fell from 5.8 weeks in August 2007 to five weeks in January 2009.

The median referral to treatment time waited of rheumatology patients admitted for treatment has come down from 15 weeks in March 2007 to 4.4 weeks in January 2009. Median referral to treatment time waited for non-admitted rheumatology patients fell from 9.3 weeks in August 2007 to 5.8 weeks in January 2009.

NHS: Drugs

Grant Shapps: To ask the Secretary of State for Health (1) what estimate he has made of the cost of prescribing anti-depressant drugs in (a) North and East Hertfordshire and (b) England in each of the last five years (i) in cash terms and (ii) in 2009-10 prices; [269646]


20 Apr 2009 : Column 475W

(2) what the average net ingredient cost was for drugs falling within section 4.3 of the British National Formulary in each of the last five years (a) in cash terms and (b) in 2009-10 prices. [269647]


20 Apr 2009 : Column 476W

Phil Hope: The information requested is in the following table.

Section 4.3 of the British National Formulary: antidepressant drugs, 2003-07
Net ingredient cost for prescription items dispensed in East and North Hertfordshire PCT( 1, 2) (£000) Uprated to 2009-10 prices( 3) Net ingredient cost for prescription items dispensed in England (£000) Uprated to 2009-10 prices( 3) Average net ingredient cost per prescription item dispensed in England (£) Uprated to 2009-10 prices( 3)

2003

n/a

n/a

395,178.0

458,466.2

14.29

16.58

2004

n/a

n/a

400,681.7

452,542.2

13.82

15.61

2005

3,375.1

3,735.4

338,546.7

374,684.0

11.52

12.75

2006

2,891.7

3,115.0

291,511.4

314,023.8

9.39

10.12

2007

2,683.7

2,812.5

276,107.6

289,357.3

8.16

8.55

(1) Data based on current primary care trust (PCT) structure. The structure changed in October 2006 when North Hertfordshire and Stevenage PCT, Royston, Buntingford and Bishop’s Stortford PCT, South East Hertfordshire PCT and Welwyn Hatfield PCT were incorporated into the new East and North Hertfordshire PCT.
(2) PCT level data supplied by the NHS Prescriptions Service is only held for a rolling 60-month period.
(3) Based on HM Treasury gross domestic product deflators.
Source:
Prescription Cost Analysis (PCA) system.

Norman Lamb: To ask the Secretary of State for Health how many patients (a) were admitted to hospital and (b) died because of an adverse reaction to prescription medication in each of the last 10 years. [269732]

Phil Hope: Reports of suspected adverse drug reactions (ADRs) are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines (CHM) through the spontaneous reporting scheme; the Yellow Card Scheme. Approximately 20,000-25,000 reports of ADRs are reported to the MHRA/CHM through this scheme each year. The scheme collects ADR reports from across the whole United Kingdom and includes all medicines, including those from prescriptions, over-the-counter or general retail sales. Reports are also received for herbal medicines and other unlicensed medicines.

The following table shows the number of spontaneous UK suspected Adverse Drug Reaction reports received by the MHRA between 1998 and 2008 which (i) had a fatal outcome (ii) resulted in or prolonged hospitalisation.

Year received by MHRA Number of spontaneous UK suspected ADR reports received Number of spontaneous UK suspected ADR reports received with a fatal outcome Number of spontaneous UK suspected ADR reports received which resulted in or prolonged hospitalisation

1998

18,047

520

2,970

1999

18,483

564

3,212

2000

33,147

632

4,060

2001

21,454

648

3,011

2002

17,602

666

3,624

2003

19,215

733

4,380

2004

19,975

859

4,426

2005

21,917

1,015

4,564

2006

22,001

952

4,621

2007

21,761

1,030

4,500

2008

25,424

1,299

4,487


It is important to note that a report of an adverse drug reaction does not necessarily mean that it was caused by the drug. Many factors have to be taken into account in assessing causal relationships including temporal association, the possible contribution of concomitant medication and the underlying disease being treated.

NHS: Equality

Mr. Clifton-Brown: To ask the Secretary of State for Health how much his Department’s Pacesetters programme is estimated to cost; how many staff of his Department are engaged on it; how long (a) Wave 1 and (b) Wave 2 is expected to last; and what assessment of the costs and benefits of the programme have been carried out. [268910]

Phil Hope: The total cost of the Pacesetter programme for 2008-09 was approximately £2 million, including an allocation of some £200,000 for each of the six participating strategic health authority (SHAs) (slight variations occur between SHAs). There are four departmental staff engaged on the programme, supported by a number of national health service secondees.

By mid-2007, 18 trusts from six SHA areas had signed up to wave 1 of the programme. Each participating trust in wave 1 has up to three years of funding allocated dependent on when they joined the programme. A further 16 trusts from six SHA areas were recruited to wave 2 in October 2008. Each participating trust in wave 2 has up to two years of funding allocated.


20 Apr 2009 : Column 477W

The equality impact assessment of the Pacesetters Programme was issued for consultation on 17 March 2009. It spells out the anticipated outcomes of and the potential challenges facing Pacesetters. Where challenges are identified, action plans to address or mitigate them are presented.

NHS: Private Sector

Mr. Swire: To ask the Secretary of State for Health what recent steps he has taken to monitor the effect of the use of private sector operators on levels of patient care quality in (a) patient transport services and (b) the NHS; and if he will make a statement. [263402]

Mr. Bradshaw: On 1 April 2009, the Care Quality Commission took over from the Healthcare Commission, the Commission for Social Care Inspection and the Mental Health Act Commission.

For 2009-10, the Commission continues to regulate private and voluntary health care and adult social care under the Care Standards Act 2000. Also for 2009-10, national health service providers have been registered against the requirement relating to health care associated infection and will continue to work to the national standards in Standards for Better Health.

From April 2010, the Care Quality Commission will start to operate a new registration system, covering both health and adult social care providers. This will be based in secondary legislation under the Health and Social Care Act 2008. Our aim is to ensure that the registration system is fair to all providers of regulated health or adult social care activities, no matter whether they are classed as health or adult social care, from the NHS, local authority or independent sectors.

In the Department's “Response to Consultation on the Framework for Registration of Health and Adult Social Care Providers and Consultation on Draft Regulations”, published on 30 March 2009, it has been announced that patient transport services will be brought within the new registration system under the 'emergency and urgent care' activity. It is also stated that private ambulance service providers will be brought into regulation from April 2011.

NHS: Training

Norman Lamb: To ask the Secretary of State for Health how much his Department spent on each type of non-medical education and training for NHS staff in each of the last five years; and what the budget for each year to 2010-11 is. [269212]

Ann Keen: Information on the amount spent by the Department on each type of non-medical education and training in each of the last five years is not held centrally. The annual allocations for non-medical education and training (NMET) for each year to 2010-11 are shown in the following table.


20 Apr 2009 : Column 478W
Annual NMET allocation

2005-06

1,721

2006-07

1,753

2007-08

1,797

2008-09

1,895

2009-10

2,000

2010-11

Not available


Northern Burn Care Network

Derek Twigg: To ask the Secretary of State for Health where the (a) network manager and (b) clinical director of the Northern Burn Care Network are based. [269306]

Ann Keen: The Northern Burn Care Network is organisationally based within Yorkshire and the Humber Specialised Commissioning Group. The network manager and clinical director are based at:


Next Section Index Home Page